Trial intelligence / Profile preview

Vitamin D in Resectable Urothelial Carcinoma

NCT04197089Phase 4Completed

Sponsor
Hospital Universitari Germans Trias i Pujol
Start
Feb 2020
Primary completion
Nov 2021
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of vitamin d in urothelial carcinoma (UC), sponsored by Hospital Universitari Germans Trias i Pujol. Started Feb 2020; status: completed.

02

Drugs

vitamin d
03

Conditions

urothelial carcinoma (UC)

Beyond the preview

Go deeper on NCT04197089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04197089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call